36 results on '"Kinge, Thompson"'
Search Results
2. How trauma patients die in low resource settings: Identifying early targets for trauma quality improvement.
3. The CBS test: Development, evaluation & cross-validation of a community-based injury severity scoring system in Cameroon.
4. Associations between social determinants of health and interpersonal violence-related injury in Cameroon: a cross-sectional study
5. Chronic Disease Comorbidities Among Injured Patients in Cameroon: A Retrospective Cohort Study
6. How trauma patients die in low resource settings: Identifying early targets for trauma quality improvement
7. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
8. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
9. Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection
10. Bystander intervention is associated with reduced mortality among injury victims in Cameroon
11. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS.
12. How trauma patients die in low resource settings: Identifying early targets for trauma quality improvement
13. Numbering questionnaires had no impact on the response rate and only a slight influence on the response content of a patient safety culture survey: a randomized trial
14. Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon
15. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
16. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS
17. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
18. Evaluation of corrective actions of feedback from clinicians on Clinical Laboratory Services at Bamenda Regional Hospital Laboratory, Cameroon
19. HIV care in Cameroon: a missed opportunity to screen for high blood pressure among adults living with HIV/AIDS?
20. The evolution of HIV‐1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations
21. Sequence Analysis of the Dimerization Initiation Site of Concordant and Discordant Viral Variants Superinfecting HIV Type 1 Patients
22. Sexual Behavior of HIV-Positive Women in Cameroon
23. Infection by Discordant Strains of HIV-1 Markedly Enhances the Neutralizing Antibody Response against Heterologous Virus
24. Longitudinal Quasispecies Analysis of Viral Variants in HIV Type 1 Dually Infected Individuals Highlights the Importance of Sequence Identity in Viral Recombination
25. HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon
26. High Frequency of HIV-1 Dual Infections Among HIV-Positive Individuals in Cameroon, West Central Africa
27. Utility of the Heteroduplex Assay (HDA) as a Simple and Cost-Effective Tool for the Identification of HIV Type 1 Dual Infections in Resource-Limited Settings
28. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals
29. The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.
30. Sexual Behavior of HIV-Positive Women in Cameroon.
31. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
32. Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity.
33. Protease Mutations in HIV-1 Non-B Strains Infecting Drug-Naive Villagers of Cameroon
34. Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity
35. Bystander intervention is associated with reduced early mortality among injury victims in Cameroon.
36. Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.